HURA
TuHURA Biosciences, Inc./NV
NASDAQ · Healthcare · Biotechnology · US
$2.10
+0.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 104.75x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.23x
- Price / sales
- —
- Price / cash flow
- -4.51x
Enterprise value
- Enterprise value
- $133.5M
- EV / sales
- —
- EV / EBITDA
- -4.54x
- EV / EBIT
- -4.28x
- Market cap
- $133.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026